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METHODS
The peptide was synthesized according to standard Fmoc-based solid
phase peptide synthesis. The structure was based on a diphenylalanine-
dilysine sequence (FFKK), which was previously shown to gelate and
display antimicrobial properties [4]. The non-steroidal anti-inflammatory
drug naproxen was conjugated to the end of the amine terminal of the
peptide sequence to confer the desired anti-inflammatory properties and a
heparin motif was incorporated to provide pro-angiogenic qualities.
Peptide gelation ability at various concentrations was examined via pH
modulation.
Hydrogels form at concentrations above the minimum gelation
concentration (MGC) (% w/v). Vial inversion assays and Scanning
Electron Microscopy were employed to examine gelation.
Bacterial susceptibility assays were performed against Gram-negative
Pseudomonas aeruginosa (PA01) and Gram-positive Staphylococcus
aureus (NCTC 10788) using the Miles and Misra drop count method.
Haemolytic activity was measured using equine erythrocytes and
biocompatibility was determined via in vitro cell culture assays to
determine cell viability using the CellTiter 96® AQueous One Solution Cell
Proliferation Assay with NCTC clone 929 (ATCC CCL 1) murine fibroblast
cells with 6, 24 and 72 hour incubation times.
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INTRODUCTION
Wound healing is a complex and dynamic process consisting of four main
steps:
In chronic wounds the wound remains in the proliferation stage with
excess inflammation occurring and fails to progress to remodeling [1].
The use of peptides represents a novel approach to enhance wound
healing. Inherent antimicrobial activity, increased biocompatibility and
tunable biodegradability render peptides more suitable for application to
the chronic wound environment than currently administered synthetic
materials [2]. Uncontrolled local inflammation and the presence of
infectious pathogens can result in the development of chronic non-healing
wounds, leading to increased patient morbidity and the failure of standard
therapies such as antibiotics [3].
The chemical versatility of the peptide motif enables three main qualities
to be incorporated into a structure which is capable of self-assembly:
Self-assembly can occur in response to a number of different infective
stimuli including pH, temperature and specific enzymes to enable targeted
action at the required site. The incorporation of multifunctional properties
overcome limitations with existing topical therapies, which fail to address a
profile of increased inflammation and microbial load, with reduced
angiogenesis that combine to prevent healing.
RESULTS AND DISCUSSION
The self-assembly process is dependent on the amino acids incorporated in the primary sequence of the peptide
structure and the formation of intermolecular interactions including Van der Waals interactions and π – π stacking.
Vial inversion assays demonstrated the formation of peptide hydrogel at a concentration of 1.5 % w/v and above and
the fibrous network was confirmed via SEM imaging with Figure 1 below showing the dense fibrous network at the
highest concentration employed.
Clinically significant Log10 reductions in the growth of Gram-negative P. aeruginosa and Gram-positive S.aureus wasobserved at higher concentrations employed, with significance denoted as at least a three Log10 reduction in viablecounts since this is commonly employed to denote clinical significance [5]. P. aeruginosa and S. aureus are the most
common ESKAPE pathogens isolated from chronic wounds and demonstrate increased resistance to topical
antibiotics [6]. There is no necessity for a sterile environment for wound healing, however, a reduction in the
bioburden can promote wound healing in the case of chronic wounds and this peptide demonstrates at least a three
log reduction against each organism at a concentration of 1.5 and 2.0 % w/v.
CONCLUSIONS
Multifunctional ultrashort peptide hydrogels demonstrate potential as wound healing products. Peptide hydrogel dressing products may resolve issues in the case of chronic wounds which fail to
heal, for example, diabetic ulcers. Future work will involve assessment of the mechanical properties of the gel structure via oscillatory rheology and wound healing properties using the in vitro
wound scratch assay to assess cell migration using the human dermal endothelium cell line HMEC-1 and the human keratinocyte cell line HaCaT [7]. In addition to this it will be possible to modify
the peptide sequence to tailor the properties to the exact desired requirements via modification of the primary sequence and incorporation of other non-steroidal anti-inflammatory drugs.
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Figure 1. Scanning electron microscope images of freeze-dried, gold-sputtered samples of naproxen-conjugated peptide at a
concentration of 2.0 % w/v at: [A] a magnification of x 1,000, [B] a magnification of x 2, 500 and [C] a magnification of x 5, 000.
Figure 2. Logarithmic reduction in P. aeruginosa (PA01) viable
count (Log10 CFU/mL) after 24 hour incubation with peptide(concentration 0.5 – 2.0 % w/v).
ns: no significant difference (P ≥ 0.05), ****: P < 0.0001
significant difference between Log10 CFU/mL of peptide and thegrowth control.
ns            ns ****      ****
Figure 3. Logarithmic reduction in S. aureus (NCTC 10788) viable
count (Log10 CFU/mL) after 24 hour incubation with peptide(concentration 0.5 – 2.0 % w/v).
ns: no significant difference (P ≥ 0.05), *: P < 0.01 and ****: P <
0.0001 significant difference between Log10 CFU/mL of peptideand the growth control.
ns            ns *         ****
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Figure 4. Percentage cytotoxicity of NCTC clone 929 (ATCC CCL 1)
cells following a 6, 24 and 72 hour incubation time (A, B and C
respectively) with varying concentrations of peptide. Black bars
show micro molar concentrations and grey bars show % w/v
concentrations. Dotted lines represent 80 % viability.
ns: no significant difference (P ≥ 0.05), ****: P < 0.0001 significant
difference between peptide treated cells and the negative control
(untreated cells).
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The MTS assay was performed to assess the viability of
cells after incubation with varying concentrations of the
peptide as an initial assessment of biocompatibility. The
micro molar concentrations employed had no significant
effect on the cell viability whilst the higher concentrations
(% w/v) showed a reduction in cell viability. The micro
molar concentrations are more likely to be reflective of
the concentrations of peptide which cells would be
exposed to since the peptide will slowly diffuse from the
gel matrix and into the surrounding environment to exert
its effect. Further studies will be necessary to assess the
biocompatibility of the peptide.
The peptide was shown to be relatively non-haemolytic at
the lower concentrations employed, with the haemolysis
observed at higher concentrations likely to be attributed
to issues with tonicity or osmolarity due to osmotic
variations in the test media resulting in over-estimation of
the toxicity.
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Figure 5. Percentage haemolysis of equine erythrocytes after one
hour exposure to varying concentrations of peptide (0.5 – 2.0 %
w/v).
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AIM
To develop a therapeutically active hydrogel network with the potential to
be employed as a dressing, where the hydrogel is applied to the wound
and conforms to its shape, whilst providing a moist environment and
enabling gas exchange at the wound site.
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